Rowan Cos. (RDC) Tops Q2 EPS by 5c
Get Alerts RDC Hot Sheet
Join SI Premium – FREE
Rowan Cos. (NYSE: RDC) reported Q2 EPS of ($0.25), $0.05 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $320.2 million versus the consensus estimate of $293.86 million.
For earnings history and earnings-related data on Rowan Cos. (RDC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c
- ImmuCell reports 46% sales increase in Q3 2026
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share